Early Ventricular Arrhythmias After Left Ventricular Assist Device Implantation

Connor P Oates; Phillip H Lam; Luke Lawrence; Grace Bigham; Namratha S Meda; Binaya Basyal; Cyrus A Hadadi; Sriram D Rao; Michael Hockstein; Manish Shah; Farooq H Sheikh

doi:10.1016/j.cardfail.2023.11.018

Early Ventricular Arrhythmias After Left Ventricular Assist Device Implantation

J Card Fail. 2023 Dec 15:S1071-9164(23)00912-0. doi: 10.1016/j.cardfail.2023.11.018. Online ahead of print.

Authors

Affiliations

¹ MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University School of Medicine, Washington, DC. Electronic address: connor.p.oates@medstar.net.
² MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University School of Medicine, Washington, DC.

PMID: 38103723
DOI: 10.1016/j.cardfail.2023.11.018

Abstract

Background: Although sustained ventricular arrhythmias (VAs) are a common complication after durable left ventricular assist device (LVAD) implantation, the incidence, risk factors, and prognostic implications of postoperative early VAs (EVAs) in contemporary patients with LVAD are poorly understood.

Methods and results: A single-center retrospective analysis was performed of patients who underwent LVAD implantation from October 1, 2006, to October 1, 2022. EVA was defined as an episode of sustained VA identified ≤30 days after LVAD implantation. A total of 789 patients underwent LVAD implantation (mean age 62.9 ± 0. years 5, HeartMate 3 41.4%, destination therapy 43.3%). EVAs occurred in 100 patients (12.7%). A history of end-stage renal disease (odds ratio [OR] 5.6, 95% confidence interval [CI] 1.45-21.70), preoperative electrical storm (OR 2.82, 95% CI 1.11-7.16), and appropriate implantable cardiac defibrillator therapy before implantation (OR 2.8, 95% CI 1.26-6.19) are independently associated with EVAs. EVA was associated with decreased 30-day survival (hazard ratio 3.02, 95% CI 1.1-8.3, P = .032). There was no difference in transplant-free survival time between patients with and without EVAs (hazard ratio 0.82, 95% CI 0.5-1.4, P = .454).

Conclusions: EVAs are common after durable LVAD implantation and are associated with an increased risk of 30-day mortality.

Keywords: Ventricular tachycardia; left ventricular assist device; ventricular fibrillation.